Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Prime Medicine, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Investor presentation, Quarterly results
Docs: "Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates",
"Prime Medicine August 2023"
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/17/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting Data demonstrated Prime Editors efficiently, reproducibly and durably corrected the causative mutation of CGD, supporting advancement of development candidate PM359"
05/11/2023 8-K Appointed a new director
05/11/2023 8-K Quarterly results
Docs: "Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates"
03/09/2023 8-K Quarterly results
Docs: "Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
01/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"Presentation at 41st Annual J.P. Morgan Healthcare Conference, dated January 2023, furnished herewith",
"Prime Medicine Announces Recent Progress and Highlights 2023 Strategic Priorities"
10/24/2022 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy